Cas no 776315-23-2 (4-bromo-3-formylbenzoic Acid)

4-Bromo-3-formylbenzoic acid is a versatile aromatic compound featuring both a bromo substituent and a formyl group on a benzoic acid backbone. This structure makes it a valuable intermediate in organic synthesis, particularly for constructing complex molecules in pharmaceuticals, agrochemicals, and materials science. The bromo group offers reactivity for cross-coupling reactions, while the formyl group enables further functionalization through condensation or reduction. Its benzoic acid moiety enhances solubility in polar solvents, facilitating purification and downstream applications. The compound’s well-defined reactivity profile and stability under standard conditions make it a reliable choice for multistep synthetic routes.
4-bromo-3-formylbenzoic Acid structure
4-bromo-3-formylbenzoic Acid structure
Product Name:4-bromo-3-formylbenzoic Acid
CAS No:776315-23-2
MF:C8H5BrO3
MW:229.027501821518
MDL:MFCD20485838
CID:1788261
PubChem ID:53393386
Update Time:2025-06-12

4-bromo-3-formylbenzoic Acid Chemical and Physical Properties

Names and Identifiers

    • 4-bromo-3-formylbenzoic Acid
    • 3-Fluor-4-brom-pyridin
    • CTK4F5843
    • 3-Fluoro-4-bromopyridinehydrochloride
    • AC1MD3XH
    • AG-E-78029
    • bromo-4 fluoro-3 pyridine
    • SureCN784834
    • Pyridine,4-bromo-3-fluoro-
    • 4-bromo-3-fluoro-pyridine
    • 4-bromo-3-formyl-benzoic acid
    • SCHEMBL615840
    • 776315-23-2
    • Benzoic acid, 4-bromo-3-formyl-
    • E91965
    • DA-39876
    • CS-0195951
    • PS-11641
    • MFCD20485838
    • AKOS015904228
    • Z1486034958
    • SY320423
    • 4-Bromo-3-formylbenzoicacid
    • EN300-146804
    • BCCWNHVSVOSFOT-UHFFFAOYSA-N
    • BGB31523
    • MDL: MFCD20485838
    • Inchi: 1S/C8H5BrO3/c9-7-2-1-5(8(11)12)3-6(7)4-10/h1-4H,(H,11,12)
    • InChI Key: BCCWNHVSVOSFOT-UHFFFAOYSA-N
    • SMILES: BrC1C=CC(C(=O)O)=CC=1C=O

Computed Properties

  • Exact Mass: 227.94215
  • Monoisotopic Mass: 227.94221g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 2
  • Complexity: 193
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.6
  • Topological Polar Surface Area: 54.4?2

Experimental Properties

  • PSA: 54.37

4-bromo-3-formylbenzoic Acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
B188135-250mg
4-Bromo-3-formylbenzoic acid
776315-23-2
250mg
$ 835.00 2022-06-07
TRC
B188135-500mg
4-Bromo-3-formylbenzoic acid
776315-23-2
500mg
$ 1395.00 2022-06-07
Matrix Scientific
189938-1g
4-Bromo-3-formylbenzoic acid
776315-23-2
1g
$900.00 2023-09-10
Matrix Scientific
189938-5g
4-Bromo-3-formylbenzoic acid
776315-23-2
5g
$2700.00 2023-09-10
Apollo Scientific
OR400762-250mg
4-Bromo-3-formylbenzoic acid
776315-23-2 95%
250mg
£110.00 2025-02-20
Apollo Scientific
OR400762-1g
4-Bromo-3-formylbenzoic acid
776315-23-2 95%
1g
£300.00 2025-02-20
abcr
AB526166-250 mg
4-Bromo-3-formylbenzoic acid; .
776315-23-2
250MG
€298.60 2022-07-29
abcr
AB526166-500 mg
4-Bromo-3-formylbenzoic acid; .
776315-23-2
500MG
€495.50 2022-07-29
abcr
AB526166-1 g
4-Bromo-3-formylbenzoic acid; .
776315-23-2
1g
€673.10 2022-07-29
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1266621-250mg
4-Bromo-3-formylbenzoic acid
776315-23-2 97%
250mg
¥1813.00 2024-07-28

4-bromo-3-formylbenzoic Acid Suppliers

Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
(CAS:776315-23-2)4-bromo-3-formylbenzoic Acid
Order Number:A1176676
Stock Status:in Stock
Quantity:1g
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 01:34
Price ($):497.0

Additional information on 4-bromo-3-formylbenzoic Acid

Introduction to 4-bromo-3-formylbenzoic Acid (CAS No. 776315-23-2)

4-bromo-3-formylbenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 776315-23-2, is a versatile organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its bromine substituent and aldehyde functional group, serves as a crucial intermediate in the synthesis of various biologically active molecules. Its unique structural properties make it a valuable building block for medicinal chemists and synthetic organic chemists alike.

The molecular structure of 4-bromo-3-formylbenzoic acid consists of a benzene ring substituted with a bromine atom at the 4-position and a formyl group at the 3-position. This arrangement imparts distinct reactivity, making it an ideal candidate for further functionalization through various chemical transformations. The presence of both electron-withdrawing and electron-donating groups on the aromatic ring enhances its utility in constructing complex scaffolds, which are often required in drug discovery processes.

In recent years, 4-bromo-3-formylbenzoic acid has been extensively studied for its potential applications in the development of novel therapeutic agents. One of the most compelling areas of research involves its use as a precursor in the synthesis of small-molecule inhibitors targeting various biological pathways. For instance, studies have demonstrated its role in generating compounds that interact with enzymes involved in cancer metabolism and inflammation. The bromine atom, in particular, provides a handle for further modifications via cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing heterocyclic frameworks.

The formyl group attached to the benzene ring in 4-bromo-3-formylbenzoic acid offers another avenue for chemical manipulation. It can be readily converted into other functional groups, including alcohols, esters, and amides, through oxidation-reduction or esterification reactions. These transformations are essential for tailoring the pharmacokinetic properties of derived compounds, ensuring optimal bioavailability and therapeutic efficacy. Moreover, the formyl group can participate in condensation reactions to form Schiff bases or other heterocyclic structures, which have shown promise in antimicrobial and anti-inflammatory applications.

Recent advancements in computational chemistry have further highlighted the significance of 4-bromo-3-formylbenzoic acid as a key intermediate. Molecular modeling studies have revealed that derivatives of this compound can effectively modulate protein-protein interactions by binding to specific pockets on target enzymes. Such insights have guided the design of more potent and selective inhibitors with improved pharmacological profiles. Additionally, high-throughput screening (HTS) campaigns have utilized libraries containing analogs of 4-bromo-3-formylbenzoic acid to identify lead compounds for further optimization.

The pharmaceutical industry has also recognized the potential of 4-bromo-3-formylbenzoic acid in developing next-generation therapeutics. Researchers have explored its incorporation into drug candidates targeting neurological disorders, where precise modulation of biological pathways is critical. The compound’s ability to undergo diverse chemical modifications allows for the creation of structurally diverse libraries, enabling rapid screening for novel pharmacophores. This flexibility has been instrumental in accelerating drug discovery pipelines and bringing new treatments to market more efficiently.

Beyond pharmaceutical applications, 4-bromo-3-formylbenzoic acid finds utility in materials science and agrochemical research. Its structural motifs have been leveraged in designing advanced materials with tailored electronic properties, such as organic semiconductors and luminescent dyes. In agrochemistry, derivatives of this compound have been investigated for their potential as bioactive agents against pests and pathogens, offering sustainable alternatives to traditional pesticides.

The synthesis of 4-bromo-3-formylbenzoic acid itself is a subject of ongoing research to improve yield and scalability. Modern synthetic methodologies focus on optimizing reaction conditions to minimize byproducts and enhance atom economy. Catalytic approaches, including transition-metal-catalyzed processes, have been particularly effective in achieving high selectivity and efficiency during its preparation. These innovations ensure that researchers have access to high-purity starting materials necessary for sensitive downstream applications.

As our understanding of biological systems continues to evolve, the demand for specialized intermediates like 4-bromo-3-formylbenzoic acid is expected to grow. Emerging fields such as precision medicine and gene therapy rely heavily on custom-designed molecules with precise targeting capabilities. The versatility of this compound positions it as a cornerstone in synthetic chemistry, enabling researchers to push the boundaries of what is possible in drug development and material innovation.

Recommended suppliers
Amadis Chemical Company Limited
(CAS:776315-23-2)4-bromo-3-formylbenzoic Acid
A1176676
Purity:99%
Quantity:1g
Price ($):497.0
Email